Search

Your search keyword '"Mendive-Tapia, Lorena"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Mendive-Tapia, Lorena" Remove constraint Author: "Mendive-Tapia, Lorena" Database MEDLINE Remove constraint Database: MEDLINE
40 results on '"Mendive-Tapia, Lorena"'

Search Results

1. Sequential replacement of PSD95 subunits in postsynaptic supercomplexes is slowest in the cortex.

2. Label-Free SERS Sensors for Real-Time Monitoring of Tyrosine Phosphorylation.

3. Chemo-Click: Receptor-Controlled and Bioorthogonal Chemokine Ligation for Real-Time Imaging of Drug-Resistant Leukemic B Cells.

4. Enzyme-Activatable Near-Infrared Hemicyanines as Modular Scaffolds for in vivo Photodynamic Therapy.

5. Nonperturbative Fluorogenic Labeling of Immunophilins Enables the Wash-free Detection of Immunosuppressants.

6. Inserting "OFF-to-ON" BODIPY Tags into Cytokines: A Fluorogenic Interleukin IL-33 for Real-Time Imaging of Immune Cells.

7. Imaging Proteins Sensitive to Direct Fusions Using Transient Peptide-Peptide Interactions.

8. Smart probes for optical imaging of T cells and screening of anti-cancer immunotherapies.

9. Acid-Resistant BODIPY Amino Acids for Peptide-Based Fluorescence Imaging of GPR54 Receptors in Pancreatic Islets.

10. Acid-Resistant BODIPY Amino Acids for Peptide-Based Fluorescence Imaging of GPR54 Receptors in Pancreatic Islets.

11. Late-stage peptide labeling with near-infrared fluorogenic nitrobenzodiazoles by manganese-catalyzed C-H activation.

12. Fluorogenic Granzyme A Substrates Enable Real-Time Imaging of Adaptive Immune Cell Activity.

13. Fluorogenic Granzyme A Substrates Enable Real-Time Imaging of Adaptive Immune Cell Activity.

14. Small Fluorogenic Amino Acids for Peptide-Guided Background-Free Imaging.

15. Small Fluorogenic Amino Acids for Peptide-Guided Background-Free Imaging.

16. A brain atlas of synapse protein lifetime across the mouse lifespan.

17. Enzyme-Activatable Chemokine Conjugates for In Vivo Targeting of Tumor-Associated Macrophages.

18. Enzyme-Activatable Chemokine Conjugates for In Vivo Targeting of Tumor-Associated Macrophages.

19. A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapies.

20. Rational Design of Phe-BODIPY Amino Acids as Fluorogenic Building Blocks for Peptide-Based Detection of Urinary Tract Candida Infections.

21. Activatable Fluorophores for Imaging Immune Cell Function.

23. A Bivalent Activatable Fluorescent Probe for Screening and Intravital Imaging of Chemotherapy-Induced Cancer Cell Death.

24. A Bivalent Activatable Fluorescent Probe for Screening and Intravital Imaging of Chemotherapy-Induced Cancer Cell Death.

25. Chemodivergent manganese-catalyzed C-H activation: modular synthesis of fluorogenic probes.

26. Activation of the Integrated Stress Response and ER Stress Protect from Fluorizoline-Induced Apoptosis in HEK293T and U2OS Cell Lines.

27. Fluorizoline-induced apoptosis requires prohibitins in nematodes and human cells.

28. A fluorogenic cyclic peptide for imaging and quantification of drug-induced apoptosis.

29. Fluorogenic Trp(redBODIPY) cyclopeptide targeting keratin 1 for imaging of aggressive carcinomas.

30. Fluorescent peptides for imaging of fungal cells.

31. Preparation of a Trp-BODIPY fluorogenic amino acid to label peptides for enhanced live-cell fluorescence imaging.

33. A Trp-BODIPY cyclic peptide for fluorescence labelling of apoptotic bodies.

34. Constrained Cyclopeptides: Biaryl Formation through Pd-Catalyzed C-H Activation in Peptides-Structural Control of the Cyclization vs. Cyclodimerization Outcome.

35. Spacer-free BODIPY fluorogens in antimicrobial peptides for direct imaging of fungal infection in human tissue.

36. Enhanced antimicrobial activity of a peptide derived from human lysozyme by arylation of its tryptophan residues.

37. New peptide architectures through C-H activation stapling between tryptophan-phenylalanine/tyrosine residues.

38. Synthesis of C-2 arylated tryptophan amino acids and related compounds through palladium-catalyzed C-H activation.

39. Understanding acid lability of cysteine protecting groups.

40. Acid-labile Cys-protecting groups for the Fmoc/tBu strategy: filling the gap.

Catalog

Books, media, physical & digital resources